Clinical Trial Update: Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis [Phase 2]

View source ↗

Summary

This report covers a Phase 2 double-blind, placebo-controlled trial of LiRIS for safety and efficacy in women with interstitial cystitis that was terminated, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• LiRIS

Snippet

Sponsor: Allergan | Conditions: Interstitial Cystitis | Phase 2 | Status: TERMINATED | Results posted: 2015-09-21